Mr. Speaker, June is ALS Awareness Month, and since today is Lou Gehrig Day, I am calling on each of us to recognize how important it is for Health Canada to speed up its review of an Amylyx treatment for ALS.
In the member's statement I made last year about this day, I shared my experience as a caregiver for my father, who had this disease for 20 years. I expressed hope that a treatment capable of slowing its progression would be found. We are close.
I urge Health Canada to work even harder to get this treatment approved quickly. Time is limited.
To all those with ALS, to their loved ones and to advocacy organizations, I say keep fighting.